Skip to content

Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG Monitoring

A Stereoelectroencephalography-Based Study of Brain Functional Modulation by Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07790224
Enrollment
60
Registered
2026-08-27
Start date
2026-08-30
Completion date
2028-12-31
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

This prospective exploratory interventional study aims to investigate the neurophysiological effects and safety of multi-parameter temporal interference (TI) stimulation in patients undergoing stereoelectroencephalography (SEEG) monitoring. Participants who have already undergone SEEG electrode implantation for clinical indications will receive non-invasive TI stimulation targeting selected deep brain regions according to their individual electrode coverage and neuroimaging data. Multiple stimulation frequencies will be tested while intracranial SEEG signals are recorded before, during, and after stimulation. The study will characterize frequency-dependent changes in local and distributed brain activity and explore the relationship between TI stimulation parameters and neurophysiological responses, providing in vivo evidence for parameter optimization of non-invasive deep brain stimulation.

Interventions

DEVICETemporal Interference Stimulation

Participants will receive individualized temporal interference (TI) stimulation targeting one or two deep brain regions selected according to SEEG electrode coverage and individual neuroimaging data. Scalp electrode placement and stimulation intensity will be optimized using individualized finite-element modeling. Multiple beat-frequency conditions corresponding to delta, theta, alpha, beta, gamma, and high-gamma frequency ranges will be administered in randomized order. SEEG activity will be recorded before, during, and after stimulation.

Sponsors

Beijing Sanbo Brain Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants are assigned to a single study arm and receive multiple temporal interference stimulation conditions in a within-participant design. For each selected deep brain target, multiple stimulation frequencies are administered in a randomized order, with SEEG activity recorded before, during, and after each stimulation condition.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18 to 70 years, inclusive, with no restriction on sex. * Has undergone stereoelectroencephalography (SEEG) electrode implantation, with electrode contacts covering the target deep brain region(s), such as the thalamus, hippocampus, amygdala, or cingulate cortex. * Is in the postoperative SEEG monitoring period, is clinically stable, and is able to comply with the study procedures. * The participant or the participant's legally authorized representative is able to fully understand the purpose and procedures of the study and voluntarily provides written informed consent.

Exclusion criteria

* Contraindications to magnetic resonance imaging (MRI), such as incompatible metallic implants or a cardiac pacemaker. * Psychiatric disorders or severe cognitive impairment. * Structural brain abnormalities, such as cerebral infarction, hydrocephalus, or severe thalamic atrophy. * Other severe neurological disorders that may interfere with participation in the study. * Medical or psychiatric contraindications, including recent myocardial infarction, cardiac arrhythmia, stroke, autonomic dysfunction, endocrine disorders, uncontrolled or difficult-to-control hypertension or hypotension, deep brain stimulation for other reasons, degenerative central nervous system disorders, or severe electrolyte disturbances. * Pregnancy or breastfeeding. * Participation in another drug or medical device clinical study within 3 months before screening. * Any other condition that, in the investigator's judgment, makes the participant unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
Change From Pre-stimulation Baseline in SEEG Power Spectral DensityOn each stimulation day (Day 1 and, if applicable, Day 2), assessed immediately before each TI stimulation condition, during the 90-second stimulation period, and immediately after completion of the stimulation condition.

Secondary

MeasureTime frame
Change in Cortical-Cortical Evoked Potential (CCEP) Amplitude Following TI StimulationOn each stimulation day (Day 1 and, if applicable, Day 2), assessed immediately before and immediately after each 90-second TI stimulation condition.

Countries

China

Contacts

CONTACTJian Zhou
zhoujian5151@163.com+86(10)85130669

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026